February 28, 2023 natcopharma-wpdmn No Comments Natco Pharma (Canada) Inc. announces the launch of PrNAT-POMALIDOMIDE Capsules, the first generic alternative to POMALYST® in Canada Read more Read More
September 20, 2022 natcopharma-wpdmn No Comments Natco Canada launches NAT-Apixaban Tablets Read More
September 1, 2021 natcopharma-wpdmn No Comments Natco Pharma (Canada) Inc. announces the launch of PrNAT-LENALIDOMIDE Capsules, the first generic alternative to Revlimid® Read more > Read More
February 26, 2021 natcopharma-wpdmn No Comments NATCO launches NAT-Bendamustine powder for suspension 25mg and 100mg, in Canada Read More
January 26, 2021 natcopharma-wpdmn No Comments NATCO launches NAT-Abiraterone tablets 250mg, in Canada Read More
